retatrutide clinical trial south korea Selling a premature fix for weight loss Reta clinical trial data &

This is exactly what my original hormone doc told me

For someone on a GLP-1 medication where transit time is already extended, this can make the difference between a comfortable daily bowel movement and going 3-4 days without one

For Q2 of this year, the company reported net product revenue of $150 million, a 72% increase year-over-year

The FDA is now considering allowing its use in supplements due to its long history of safe use

The rationale: the GIP receptor arm of tirzepatide adds a new pharmacological dimension that the body has not adapted to, and the standard titration schedule minimizes gastrointestinal adverse effects